(NASDAQ:KNSA), LONDON, July 24, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution. A live webcast will be accessible through […]
Shareholders of iRobot Corporation Should Contact The Gross Law Firm Before September 5, 2025 to Discuss Your Rights – IRBT GlobeNewswire July 24, 2025 NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of iRobot Corporation (NASDAQ: IRBT). Shareholders who purchased shares of IRBT during the
Shareholders of PepGen Inc. Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your Rights – PEPG GlobeNewswire July 24, 2025 NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN GlobeNewswire July 24, 2025 NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN). Shareholders who purchased shares of BHVN during
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 GlobeNewswire July 24, 2025 LONDON, July 24, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its
Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq GlobeNewswire July 24, 2025 – Special Meeting of Stockholders to be Held Virtually on September 5, 2025 – – Live Stockholder Fireside Chat to be Scheduled to Answer Frequently Asked Stockholder Questions – – Nasdaq Hearings Panel Meeting Scheduled on
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer GlobeNewswire July 24, 2025 MINNEAPOLIS, July 24, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the first patient has
Shore Bancshares, Inc. (NASDAQ: SHBI) (the “Company” or “Shore Bancshares”), the holding company for Shore United Bank, N.A. (the “Bank”) reported net income for the second quarter of 2025 of $15.5 million, or $0.46 per diluted common share, compared to net income of $13.8 million, or $0.41 per diluted common share for the first quarter
Woodward Announces Declaration of Dividend GlobeNewswire July 24, 2025 FORT COLLINS, Colo., July 24, 2025 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ:WWD) today announced that its Board of Directors declared a cash dividend of $0.28 per share for the quarter, payable on September 4, 2025, for stockholders of record as of August 21, 2025. About Woodward,
Burke & Herbert Financial Services Corp. (the “Company” or “Burke & Herbert”) (Nasdaq: BHRB) reported financial results for the quarter year ended June30, 2025, and disclosed that, at its meeting on July24, 2025, the board of directors declared a $0.55 per share regular cash dividend to be paid on September2, 2025, to shareholders of record